J Green et al. JPGN 2025; Open Access! ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4–18 years

Overall, this article notes that the evidence based for most treatments for pediatric irritable bowel (IBS) is often lacking.

Specific recommendations:

Executive summary of Best Practice Statements‐ The Guideline Development Group (GDG) notes that a crucial emphasis should be placed on education regarding the abdominal pain‐related disorders of gut–brain interaction.

My take: This is a helpful guideline and likely to influence practice.

Related blog posts:

• AGA Guidelines for Pharmacologic Therapy of IBS-D and IBS-C (2022)
• ACG IBS Clinical Guidelines (2022)
• Does a Less Restrictive Low FODMAP Diet Work?
• “How to Approach a Patient with Difficult-to-Treat IBS”
• Gluten-Free Diet –Role in IBS?
• Briefly Noted: Kiwi for IBS-C
• Good Study, Bad Practice: Placebo for IBS and Functional Abdominal Pain
• Low Quality Evidence for IBS Dietary Therapy
• Low FODMAPs Diet in Pediatric Irritable Bowel